Collegium Pharmaceutical, Inc. (COLL)Eventide Asset Management, LLC reduced its stake -452K shares

1.42M

Shares reported · -452K vs prior quarter

0.78%

Disclosed portfolio weight

$47.1M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 18, 2026InsiderOfficer sold ~$488K of COLL shares in the open market
2. Mar 19, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
3. Apr 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, the board of directors (“Board”) of Collegium Pharmaceutical, Inc. (the “Company”) approved the nomination of Michael Donovan to stand for election at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”).”
4. May 7, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
5. May 11, 2026InsiderDirector sold ~$323K of COLL shares in the open market
6. May 12, 2026Company filing · Form 8-K · Acquisition or sale, Executive changeCompleted buying or selling a business or assets, and changed a top executive or board member (and 1 more item)“On May 11, 2026, the Company’s board of directors adopted the Company’s 2026 Inducement Plan (the “ Inducement Plan ”), pursuant to which the Company may grant non-qualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, and dividend equivalent rights with respect to an aggregate of 325,000 shares of the Company’s common stock, par value $0.001…”
7. May 13, 2026InsiderDirector sold ~$162K of COLL shares in the open market
8. May 15, 2026InsiderDirector sold ~$143K of COLL shares in the open market

What came next

1. May 18, 2026InsiderDirector sold ~$681 of COLL shares in the open market
2. Aug 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Collegium Pharmaceutical, Inc.

For Collegium Pharmaceutical, Inc., OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COLL page.

How this filing works

• SEC Form 13F

Other disclosures at Collegium Pharmaceutical, Inc.

• SEC Form 13F-HRAug 14, 2026
• SEC Form 4May 20, 2026
• SEC Form 4May 18, 2026
• SEC Form 4May 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4May 13, 2026

Everything OQRO holds on this company is on its COLL page.